IDEXX Laboratories Inc (IDXX)
418.55
-0.06
(-0.01%)
USD |
NASDAQ |
Nov 21, 16:00
428.99
+10.44
(+2.49%)
After-Hours: 05:14
IDEXX Laboratories Revenue (Quarterly): 975.54M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 975.54M |
| June 30, 2024 | 1.004B |
| March 31, 2024 | 964.10M |
| December 31, 2023 | 901.60M |
| September 30, 2023 | 915.53M |
| June 30, 2023 | 943.63M |
| March 31, 2023 | 900.20M |
| December 31, 2022 | 828.57M |
| September 30, 2022 | 841.66M |
| June 30, 2022 | 860.55M |
| March 31, 2022 | 836.55M |
| December 31, 2021 | 801.09M |
| September 30, 2021 | 810.42M |
| June 30, 2021 | 826.14M |
| March 31, 2021 | 777.71M |
| December 31, 2020 | 720.94M |
| September 30, 2020 | 721.79M |
| June 30, 2020 | 637.59M |
| March 31, 2020 | 626.34M |
| December 31, 2019 | 605.45M |
| September 30, 2019 | 605.30M |
| June 30, 2019 | 620.10M |
| March 31, 2019 | 576.06M |
| December 31, 2018 | 549.39M |
| September 30, 2018 | 545.45M |
| Date | Value |
|---|---|
| June 30, 2018 | 580.75M |
| March 31, 2018 | 537.66M |
| December 31, 2017 | 506.12M |
| September 30, 2017 | 491.98M |
| June 30, 2017 | 508.94M |
| March 31, 2017 | 462.02M |
| December 31, 2016 | 443.00M |
| September 30, 2016 | 448.31M |
| June 30, 2016 | 466.57M |
| March 31, 2016 | 417.55M |
| December 31, 2015 | 399.68M |
| September 30, 2015 | 406.39M |
| June 30, 2015 | 413.34M |
| March 31, 2015 | 382.48M |
| December 31, 2014 | 351.96M |
| September 30, 2014 | 383.52M |
| June 30, 2014 | 390.12M |
| March 31, 2014 | 360.20M |
| December 31, 2013 | 354.07M |
| September 30, 2013 | 338.30M |
| June 30, 2013 | 352.58M |
| March 31, 2013 | 332.11M |
| December 31, 2012 | 319.54M |
| September 30, 2012 | 315.48M |
| June 30, 2012 | 335.65M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
605.45M
Minimum
Dec 2019
1.004B
Maximum
Jun 2024
824.95M
Average
832.56M
Median
Revenue (Quarterly) Benchmarks
| Agilent Technologies Inc | 1.578B |
| Bio-Rad Laboratories Inc | 649.73M |
| Regeneron Pharmaceuticals Inc | 3.721B |
| West Pharmaceutical Services Inc | 746.90M |
| NovaBay Pharmaceuticals Inc | 2.441M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 232.84M |
| Total Expenses (Quarterly) | 671.65M |
| EPS Diluted (Quarterly) | 2.80 |
| Enterprise Value | 34.84B |
| Gross Profit Margin (Quarterly) | 61.10% |
| Profit Margin (Quarterly) | 23.87% |
| Earnings Yield | 2.48% |
| Operating Earnings Yield | 3.18% |
| Normalized Earnings Yield | 2.478 |